Price
Target price
-
-
-
-
-
?64.19
WKN: A3EDH2 / Symbol: TNXP / Name: Tonix Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tonix Pharmaceuticals Holding Corp. Stock
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Tonix Pharmaceuticals Holding Corp. is rather balanced.
With a target price of 64 € there is potential for a 2169.5% increase which would mean more than doubling the current price of 2.82 € for Tonix Pharmaceuticals Holding Corp..
Our community identified positive and negative aspects for Tonix Pharmaceuticals Holding Corp. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tonix Pharmaceuticals Holding Corp. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 5.570% | 2.840% | 1.187% | 5.509% | 6.465% | 176.349% | -3.856% |
| Krystal Biotech | 0.330% | 3.678% | 18.962% | 25.776% | 37.057% | 193.803% | - |
| Evolus Inc | -4.200% | -1.724% | -8.065% | -47.706% | -45.714% | -18.571% | 88.742% |
Comments
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
